Recent

% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

  • culleyjc52 culleyjc52 Apr 8, 2014 6:51 PM Flag

    Today SEC filing

    What does the following mean, I think it is good as if it was bad, they would have to disclose:

    Threshold Pharmaceuticals, Inc. submitted an application under Rule 24b-2
    requesting confidential treatment for information it excluded from the Exhibits to a Form
    10-K filed on March 6, 2014

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Too further clarify,

      Based on representations by Threshold Pharmaceuticals, Inc. that this information
      qualifies as confidential commercial or financial information under the Freedom of
      Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
      not to publicly disclose it. Accordingly, excluded information from the following exhibit
      will not be released to the public for the time period specified:
      Exhibit 10.11 through May 2, 2022

      And Exhibit 10.11 is titled:

      10.11*†† Amendment to License and Co-Development Agreement between the Registrant and Merck KGaA, dated December 2, 2013.

    • we will never know since it is confidential right? its probably some kind of deal with MERCK to sell the company at reaching certain milestone... like selling for $30 when FDA approves STS, etc.

      I agree if it was bad, they need to disclose.

      Hold your hats, i have a great feeling about THLD. All points to good results. I would be shocked if we get two bad PHase 3 trials in a row, esp the PC one, as the Phase II was very good with big sample. we'll get our multibagger w/ in 1.5 years at the worst imo.

 
THLD
4.18+0.01(+0.24%)Jul 27 4:00 PMEDT